New antibody drug targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This study tests a new drug called TST001 in people with advanced solid tumors that have spread or cannot be removed by surgery. The drug targets a protein called Claudin18.2 found on some cancer cells. The main goals are to check safety, find the best dose, and see if it helps s…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC